Opioid Induced Constipation Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_00100913
- Format: Electronic (PDF)
- Publish Type:
- Number of Pages: 250
Market Snapshot
CAGR:6.99
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 6.99 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
The report forecast global Opioid-Induced Constipation market to grow to reach xx Million USD in 2020 with a CAGR of xx% during the period 2020-2027. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue. Estimates of the regional markets for Opioid-Induced Constipation are based on the applications market.The report offers detailed coverage of Opioid-Induced Constipation industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Opioid-Induced Constipation by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Opioid-Induced Constipation market are discussed.
The market is segmented by types:
Methylnaltrexone Bromide
Lubiprostone
Naloxegol
Others
It can be also divided by applications:
Hospital
Pharmacy
And this report covers the historical situation, present status and the future prospects of the global Opioid-Induced Constipation market for 2015-2027. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.
Finally, the report provides detailed profile and data information analysis of leading company.
Takeda Pharmaceuticals
Bayer
Sanofi
Mallinckrodt
Salix (Bausch Health)
AstraZeneca
Progenics Pharmaceuticals
Purdue Pharm
Nektar Therapeutics
Daiichi Sankyo
Prestige
GSK
Shionogi
Report Includes:
- xx data tables and xx additional tables
- An overview of global Opioid-Induced Constipation market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2027
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Opioid-Induced Constipation market
- Profiles of major players in the industry, including Takeda Pharmaceuticals, Bayer, Sanofi, Mallinckrodt, Salix (Bausch Health).....
Research objectives
To study and analyze the global Opioid-Induced Constipation consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2027.
To understand the structure of Opioid-Induced Constipation market by identifying its various subsegments.
Focuses on the key global Opioid-Induced Constipation manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
To analyze the Opioid-Induced Constipation with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Opioid-Induced Constipation submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Opioid-Induced Constipation Market Report 2020, Forecast to 2025
1 Scope of the Study
1.1 Opioid-Induced Constipation Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Opioid-Induced Constipation Industry Overview
2.1 Global Opioid-Induced Constipation Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 Opioid-Induced Constipation Global Import Market Analysis
2.1.2 Opioid-Induced Constipation Global Export Market Analysis
2.1.3 Opioid-Induced Constipation Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Methylnaltrexone Bromide
2.2.2 Lubiprostone
2.2.3 Naloxegol
2.2.4 Others
2.3.2 Pharmacy
2.4.2 Global Opioid-Induced Constipation Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Opioid-Induced Constipation Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Opioid-Induced Constipation Manufacturer Market Share
2.4.5 Top 10 Opioid-Induced Constipation Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Opioid-Induced Constipation Market
2.4.7 Key Manufacturers Opioid-Induced Constipation Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Opioid-Induced Constipation Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Opioid-Induced Constipation Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Opioid-Induced Constipation Market Size Categorized by Regions
4.1 Global Opioid-Induced Constipation Revenue, Sales and Market Share by Regions
4.1.1 Global Opioid-Induced Constipation Sales and Market Share by Regions (2015-2020)
4.1.2 Global Opioid-Induced Constipation Revenue and Market Share by Regions (2015-2020)
4.2 Europe Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
4.3 APAC Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
4.4 North America Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
4.5 South America Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
5 Europe Opioid-Induced Constipation Market Size Categorized by Countries
5.1 Europe Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
5.1.1 Europe Opioid-Induced Constipation Sales by Countries (2015-2020)
5.1.2 Europe Opioid-Induced Constipation Revenue by Countries (2015-2020)
5.1.3 Germany Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
5.1.4 UK Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
5.1.5 France Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
5.1.6 Russia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
5.1.7 Italy Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
5.1.8 Spain Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
5.2 Europe Opioid-Induced Constipation Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Opioid-Induced Constipation Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Opioid-Induced Constipation Sales Market Share by Type (2015-2020)
5.3.2 Europe Opioid-Induced Constipation Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Opioid-Induced Constipation Sales Market Share by Application (2015-2020)
6 Asia-Pacific Opioid-Induced Constipation Market Size Categorized by Countries
6.1 Asia-Pacific Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Opioid-Induced Constipation Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Opioid-Induced Constipation Revenue by Countries (2015-2020)
6.1.3 China Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
6.1.4 Japan Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
6.1.5 Korea Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
6.1.6 India Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
6.1.8 Australia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Opioid-Induced Constipation Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Opioid-Induced Constipation Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Opioid-Induced Constipation Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Opioid-Induced Constipation Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Opioid-Induced Constipation Sales and Market Share by Application (2015-2020)
7 North America Opioid-Induced Constipation Market Size Categorized by Countries
7.1 North America Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
7.1.1 North America Opioid-Induced Constipation Sales by Countries (2015-2020)
7.1.2 North America Opioid-Induced Constipation Revenue by Countries (2015-2020)
7.1.3 United States Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
7.1.4 Canada Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
7.1.5 Mexico Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
7.2 North America Opioid-Induced Constipation Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Opioid-Induced Constipation Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Opioid-Induced Constipation Sales Market Share by Type (2015-2020)
7.3.2 North America Opioid-Induced Constipation Revenue and Revenue Share by Type (2015-2020)
7.4 North America Opioid-Induced Constipation Sales Market Share by Application (2015-2020)
8 South America Opioid-Induced Constipation Market Size Categorized by Countries
8.1 South America Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
8.1.1 South America Opioid-Induced Constipation Sales by Countries (2015-2020)
8.1.2 South America Opioid-Induced Constipation Revenue by Countries (2015-2020)
8.1.3 Brazil Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
8.2 South America Opioid-Induced Constipation Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Opioid-Induced Constipation Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Opioid-Induced Constipation Sales Market Share by Type (2015-2020)
8.3.2 South America Opioid-Induced Constipation Revenue and Revenue Share by Type (2015-2020)
8.4 South America Opioid-Induced Constipation Sales Market Share by Application (2015-2020)
9 Middle East and Africa Opioid-Induced Constipation Market Size Categorized by Countries
9.1 Middle East and Africa Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Opioid-Induced Constipation Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Opioid-Induced Constipation Revenue by Countries (2015-2020)
9.1.3 GCC Countries Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
9.1.4 Turkey Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
9.1.5 Egypt Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
9.1.6 South Africa Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Opioid-Induced Constipation Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Opioid-Induced Constipation Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Opioid-Induced Constipation Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Opioid-Induced Constipation Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Opioid-Induced Constipation Sales Market Share by Application (2015-2020)
10 Global Opioid-Induced Constipation Market Segment by Type
10.1 Global Opioid-Induced Constipation Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Opioid-Induced Constipation Sales and Market Share by Type (2015-2020)
10.1.2 Global Opioid-Induced Constipation Revenue and Market Share by Type (2015-2020)
10.2 Methylnaltrexone Bromide Sales Growth Rate and Price
10.2.1 Global Methylnaltrexone Bromide Sales Growth Rate (2015-2020)
10.2.2 Global Methylnaltrexone Bromide Price (2015-2020)
10.3 Lubiprostone Sales Growth Rate and Price
10.3.1 Global Lubiprostone Sales Growth Rate (2015-2020)
10.3.2 Global Lubiprostone Price (2015-2020)
10.4 Naloxegol Sales Growth Rate and Price
10.4.1 Global Naloxegol Sales Growth Rate (2015-2020)
10.4.2 Global Naloxegol Price (2015-2020)
10.5 Others Sales Growth Rate and Price
10.5.1 Global Others Sales Growth Rate (2015-2020)
10.5.2 Global Others Price (2015-2020)
11.1 Global Opioid-Induced ConstipationSales Market Share by Application (2015-2020)
11.2 Hospital Sales Growth Rate (2015-2020)
11.3 Pharmacy Sales Growth Rate (2015-2020)
12.1 Global Opioid-Induced Constipation Revenue, Sales and Growth Rate (2020-2025)
12.2 Opioid-Induced Constipation Market Forecast by Regions (2020-2025)
12.2.1 Europe Opioid-Induced Constipation Market Forecast (2020-2025)
12.2.2 APAC Opioid-Induced Constipation Market Forecast (2020-2025)
12.2.3 North America Opioid-Induced Constipation Market Forecast (2020-2025)
12.2.4 South America Opioid-Induced Constipation Market Forecast (2020-2025)
12.2.5 Middle East & Africa Opioid-Induced Constipation Market Forecast (2020-2025)
12.3 Opioid-Induced Constipation Market Forecast by Type (2020-2025)
12.3.1 Global Opioid-Induced Constipation Sales Forecast by Type (2020-2025)
12.3.2 Global Opioid-Induced Constipation Market Share Forecast by Type (2020-2025)
12.4 Opioid-Induced Constipation Market Forecast by Application (2020-2025)
12.4.1 Global Opioid-Induced Constipation Sales Forecast by Application (2020-2025)
12.4.2 Global Opioid-Induced Constipation Market Share Forecast by Application (2020-2025)
13 Analysis of Opioid-Induced Constipation Industry Key Manufacturers
13.1 Takeda Pharmaceuticals
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Takeda Pharmaceuticals Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Takeda Pharmaceuticals News
13.2 Bayer
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Bayer Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Bayer News
13.3 Sanofi
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Sanofi Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Sanofi News
13.4 Mallinckrodt
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Mallinckrodt Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Mallinckrodt News
13.5 Salix (Bausch Health)
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Salix (Bausch Health) Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Salix (Bausch Health) News
13.6 AstraZeneca
13.6.1 Company Details
13.6.2 Product Information
13.6.3 AstraZeneca Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 AstraZeneca News
13.7 Progenics Pharmaceuticals
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Progenics Pharmaceuticals Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Progenics Pharmaceuticals News
13.8 Purdue Pharm
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Purdue Pharm Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Purdue Pharm News
13.9 Nektar Therapeutics
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Nektar Therapeutics Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Nektar Therapeutics News
13.10 Daiichi Sankyo
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Daiichi Sankyo Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Daiichi Sankyo News
13.11 Prestige
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Prestige Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.11.4 Main Business Overview
13.11.5 Prestige News
13.12 GSK
13.12.1 Company Details
13.12.2 Product Information
13.12.3 GSK Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.12.4 Main Business Overview
13.12.5 GSK News
13.13 Shionogi
13.13.1 Company Details
13.13.2 Product Information
13.13.3 Shionogi Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.13.4 Main Business Overview
13.13.5 Shionogi News
15 Appendix
List of Tables and Figures
Figure Opioid-Induced Constipation Picture
Figure Research Programs/Design for This Report
Figure Global Opioid-Induced Constipation Market by Regions (2019)
Table Global Market Opioid-Induced Constipation Comparison by Regions (M USD) 2019-2025
Table Global Opioid-Induced Constipation Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Opioid-Induced Constipation by Type in 2019
Figure Methylnaltrexone Bromide Picture
Figure Lubiprostone Picture
Figure Naloxegol Picture
Figure Others Picture
Figure Hospital Picture
Figure Pharmacy Picture
Table Global Opioid-Induced Constipation Revenue by Manufacturer (2018-2020)
Figure Global Opioid-Induced Constipation Revenue Market Share by Manufacturer in 2019
Table Global Opioid-Induced Constipation Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Opioid-Induced Constipation Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Opioid-Induced Constipation Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Opioid-Induced Constipation Market
Table Key Manufacturers Opioid-Induced Constipation Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioid-Induced Constipation
Table Key Players of Upstream Markets
Table Sales Channel
Figure Sales Channel
Figure Direct Channel Pros & Cons
Table Opioid-Induced Constipation Distributors List
Table Opioid-Induced Constipation Customers List
Figure Global Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Global Opioid-Induced Constipation Revenue and Growth Rate (2015-2020)
Table Global Opioid-Induced Constipation Sales by Regions (2015-2020)
Figure Global Opioid-Induced Constipation Sales Market Share by Regions in 2019
Table Global Opioid-Induced Constipation Revenue by Regions (2015-2020)
Figure Global Opioid-Induced Constipation Revenue Market Share by Regions in 2019
Figure Europe Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure APAC Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure North America Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure South America Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Middle East & Africa Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Europe Opioid-Induced Constipation Revenue and Growth Rate (2015-2020)
Table Europe Opioid-Induced Constipation Sales by Countries (2015-2020)
Table Europe Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)
Figure Europe Opioid-Induced Constipation Sales Market Share by Countries in 2019
Table Europe Opioid-Induced Constipation Revenue by Countries (2015-2020)
Table Europe Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)
Table Europe Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)
Figure Europe Opioid-Induced Constipation Revenue Market Share by Countries in 2019
Figure Germany Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure UK Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure France Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Russia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Italy Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Spain Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Table Europe Opioid-Induced Constipation Revenue by Manufacturer (2018-2020)
Figure Europe Opioid-Induced Constipation Revenue Market Share by Manufacturer in 2019
Table Europe Opioid-Induced Constipation Sales by Type (2015-2020)
Table Europe Opioid-Induced Constipation Sales Share by Type (2015-2020)
Table Europe Opioid-Induced Constipation Revenue by Type (2015-2020)
Table Europe Opioid-Induced Constipation Revenue Share by Type (2015-2020)
Table Europe Opioid-Induced Constipation Sales by Application (2015-2020)
Table Europe Opioid-Induced Constipation Sales Share by Application (2015-2020)
Figure Asia-Pacific Opioid-Induced Constipation Revenue and Growth Rate (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Sales by Countries (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)
Figure Asia-Pacific Opioid-Induced Constipation Sales Market Share by Countries in 2019
Table Asia-Pacific Opioid-Induced Constipation Revenue by Countries (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific Opioid-Induced Constipation Revenue Market Share by Countries in 2019
Figure China Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Japan Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Korea Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure India Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Australia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Revenue by Manufacturer (2018-2020)
Figure Asia-Pacific Opioid-Induced Constipation Revenue Market Share by Manufacturer in 2019
Table Asia-Pacific Opioid-Induced Constipation Sales by Type (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Sales Share by Type (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Revenue by Type (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Revenue Share by Type (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Sales by Application (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Sales Share by Application (2015-2020)
Figure North America Opioid-Induced Constipation Revenue and Growth Rate (2015-2020)
Table North America Opioid-Induced Constipation Sales by Countries (2015-2020)
Table North America Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)
Figure North America Opioid-Induced Constipation Sales Market Share by Countries in 2019
Table North America Opioid-Induced Constipation Revenue by Countries (2015-2020)
Table North America Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)
Figure North America Opioid-Induced Constipation Revenue Market Share by Countries in 2019
Figure United States Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Canada Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Mexico Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Table North America Opioid-Induced Constipation Revenue by Manufacturer (2018-2020)
Figure North America Opioid-Induced Constipation Revenue Market Share by Manufacturer in 2019
Table North America Opioid-Induced Constipation Sales by Type (2015-2020)
Table North America Opioid-Induced Constipation Sales Share by Type (2015-2020)
Table North America Opioid-Induced Constipation Revenue by Type (2015-2020)
Table North America Opioid-Induced Constipation Revenue Share by Type (2015-2020)
Table North America Opioid-Induced Constipation Sales by Application (2015-2020)
Table North America Opioid-Induced Constipation Sales Share by Application (2015-2020)
Figure South America Opioid-Induced Constipation Revenue and Growth Rate (2015-2020)
Table South America Opioid-Induced Constipation Sales by Countries (2015-2020)
Table South America Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)
Figure South America Opioid-Induced Constipation Sales Market Share by Countries in 2019
Table South America Opioid-Induced Constipation Revenue by Countries (2015-2020)
Table South America Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)
Figure South America Opioid-Induced Constipation Revenue Market Share by Countries in 2019
Figure Brazil Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Table South America Opioid-Induced Constipation Revenue by Manufacturer (2018-2020)
Figure South America Opioid-Induced Constipation Revenue Market Share by Manufacturer in 2019
Table South America Opioid-Induced Constipation Sales by Type (2015-2020)
Table South America Opioid-Induced Constipation Sales Share by Type (2015-2020)
Table South America Opioid-Induced Constipation Revenue by Type (2015-2020)
Table South America Opioid-Induced Constipation Revenue Share by Type (2015-2020)
Table South America Opioid-Induced Constipation Sales by Application (2015-2020)
Table South America Opioid-Induced Constipation Sales Share by Application (2015-2020)
Figure Middle East and Africa Opioid-Induced Constipation Revenue and Growth Rate (2015-2020)
Table Middle East and Africa Opioid-Induced Constipation Sales by Countries (2015-2020)
Table Middle East and Africa Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)
Figure Middle East and Africa Opioid-Induced Constipation Sales Market Share by Countries in 2019
Table Middle East and Africa Opioid-Induced Constipation Revenue by Countries (2015-2020)
Table Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Countries in 2019
Figure GCC Countries Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Egypt Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Turkey Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure South Africa Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Table Middle East and Africa Opioid-Induced Constipation Revenue by Manufacturer (2018-2020)
Figure Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Manufacturer in 2019
Table Middle East and Africa Opioid-Induced Constipation Sales by Type (2015-2020)
Table Middle East and Africa Opioid-Induced Constipation Sales Share by Type (2015-2020)
Table Middle East and Africa Opioid-Induced Constipation Revenue by Type (2015-2020)
Table Middle East and Africa Opioid-Induced Constipation Revenue Share by Type (2015-2020)
Table Middle East and Africa Opioid-Induced Constipation Sales by Application (2015-2020)
Table Middle East and Africa Opioid-Induced Constipation Sales Share by Application (2015-2020)
Table Global Opioid-Induced Constipation Sales by Type (2015-2020)
Table Global Opioid-Induced Constipation Sales Market Share by Type (2015-2020)
Figure Global Opioid-Induced Constipation Sales Market Share by Type in 2019
Table Global Opioid-Induced Constipation Revenue by Type (2015-2020)
Table Global Opioid-Induced Constipation Revenue Market Share by Type (2015-2020)
Figure Global Opioid-Induced Constipation Revenue Market Share by Type in 2019
Figure Global Methylnaltrexone Bromide Sales Growth Rate (2015-2020)
Figure Global Methylnaltrexone Bromide Price (2015-2020)
Figure Global Lubiprostone Sales Growth Rate (2015-2020)
Figure Global Lubiprostone Price (2015-2020)
Figure Global Naloxegol Sales Growth Rate (2015-2020)
Figure Global Naloxegol Price (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Figure Global Opioid-Induced Constipation Sales Market Share by Application in 2019
Figure Global Hospital Sales Growth Rate (2015-2020)
Figure Global Pharmacy Sales Growth Rate (2015-2020)
Table Global Opioid-Induced Constipation Sales Forecast by Regions (2020-2025)
Table Global Opioid-Induced Constipation Market Share Forecast by Regions (2020-2025
Figure Europe Sales Opioid-Induced Constipation Market Forecast (2020-2025)
Figure APAC Sales Opioid-Induced Constipation Market Forecast (2020-2025)
Figure North America Sales Opioid-Induced Constipation Market Forecast (2020-2025)
Figure South America Sales Opioid-Induced Constipation Market Forecast (2020-2025)
Figure Middle East & Africa Sales Opioid-Induced Constipation Market Forecast (2020-2025)
Table Global Opioid-Induced Constipation Sales Forecast by Type (2020-2025)
Table Global Opioid-Induced Constipation Market Share Forecast by Type (2020-2025)
Table Global Opioid-Induced Constipation Sales Forecast by Application (2020-2025)
Table Global Opioid-Induced Constipation Market Share Forecast by Application (2020-2025)
Table Takeda Pharmaceuticals Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Takeda Pharmaceuticals
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Takeda Pharmaceuticals Opioid-Induced Constipation Market Share (2018-2020)
Table Takeda Pharmaceuticals Main Business
Table Takeda Pharmaceuticals Recent Development
Table Bayer Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Bayer
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bayer Opioid-Induced Constipation Market Share (2018-2020)
Table Bayer Main Business
Table Bayer Recent Development
Table Sanofi Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Sanofi
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sanofi Opioid-Induced Constipation Market Share (2018-2020)
Table Sanofi Main Business
Table Sanofi Recent Development
Table Mallinckrodt Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Mallinckrodt
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Mallinckrodt Opioid-Induced Constipation Market Share (2018-2020)
Table Mallinckrodt Main Business
Table Mallinckrodt Recent Development
Table Salix (Bausch Health) Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Salix (Bausch Health)
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Salix (Bausch Health) Opioid-Induced Constipation Market Share (2018-2020)
Table Salix (Bausch Health) Main Business
Table Salix (Bausch Health) Recent Development
Table AstraZeneca Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of AstraZeneca
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure AstraZeneca Opioid-Induced Constipation Market Share (2018-2020)
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Progenics Pharmaceuticals Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Progenics Pharmaceuticals
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Progenics Pharmaceuticals Opioid-Induced Constipation Market Share (2018-2020)
Table Progenics Pharmaceuticals Main Business
Table Progenics Pharmaceuticals Recent Development
Table Purdue Pharm Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Purdue Pharm
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Purdue Pharm Opioid-Induced Constipation Market Share (2018-2020)
Table Purdue Pharm Main Business
Table Purdue Pharm Recent Development
Table Nektar Therapeutics Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Nektar Therapeutics
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Nektar Therapeutics Opioid-Induced Constipation Market Share (2018-2020)
Table Nektar Therapeutics Main Business
Table Nektar Therapeutics Recent Development
Table Daiichi Sankyo Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Daiichi Sankyo
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Daiichi Sankyo Opioid-Induced Constipation Market Share (2018-2020)
Table Daiichi Sankyo Main Business
Table Daiichi Sankyo Recent Development
Table Prestige Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Prestige
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Prestige Opioid-Induced Constipation Market Share (2018-2020)
Table Prestige Main Business
Table Prestige Recent Development
Table GSK Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of GSK
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure GSK Opioid-Induced Constipation Market Share (2018-2020)
Table GSK Main Business
Table GSK Recent Development
Table Shionogi Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Shionogi
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Shionogi Opioid-Induced Constipation Market Share (2018-2020)
Table Shionogi Main Business
Table Shionogi Recent Development
Global Opioid-Induced Constipation Market Report 2020, Forecast to 2025
1 Scope of the Study
1.1 Opioid-Induced Constipation Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Opioid-Induced Constipation Industry Overview
2.1 Global Opioid-Induced Constipation Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 Opioid-Induced Constipation Global Import Market Analysis
2.1.2 Opioid-Induced Constipation Global Export Market Analysis
2.1.3 Opioid-Induced Constipation Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Methylnaltrexone Bromide
2.2.2 Lubiprostone
2.2.3 Naloxegol
2.2.4 Others
2.3.2 Pharmacy
2.4.2 Global Opioid-Induced Constipation Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Opioid-Induced Constipation Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Opioid-Induced Constipation Manufacturer Market Share
2.4.5 Top 10 Opioid-Induced Constipation Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Opioid-Induced Constipation Market
2.4.7 Key Manufacturers Opioid-Induced Constipation Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Opioid-Induced Constipation Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Opioid-Induced Constipation Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Opioid-Induced Constipation Market Size Categorized by Regions
4.1 Global Opioid-Induced Constipation Revenue, Sales and Market Share by Regions
4.1.1 Global Opioid-Induced Constipation Sales and Market Share by Regions (2015-2020)
4.1.2 Global Opioid-Induced Constipation Revenue and Market Share by Regions (2015-2020)
4.2 Europe Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
4.3 APAC Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
4.4 North America Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
4.5 South America Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
5 Europe Opioid-Induced Constipation Market Size Categorized by Countries
5.1 Europe Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
5.1.1 Europe Opioid-Induced Constipation Sales by Countries (2015-2020)
5.1.2 Europe Opioid-Induced Constipation Revenue by Countries (2015-2020)
5.1.3 Germany Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
5.1.4 UK Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
5.1.5 France Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
5.1.6 Russia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
5.1.7 Italy Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
5.1.8 Spain Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
5.2 Europe Opioid-Induced Constipation Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Opioid-Induced Constipation Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Opioid-Induced Constipation Sales Market Share by Type (2015-2020)
5.3.2 Europe Opioid-Induced Constipation Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Opioid-Induced Constipation Sales Market Share by Application (2015-2020)
6 Asia-Pacific Opioid-Induced Constipation Market Size Categorized by Countries
6.1 Asia-Pacific Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Opioid-Induced Constipation Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Opioid-Induced Constipation Revenue by Countries (2015-2020)
6.1.3 China Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
6.1.4 Japan Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
6.1.5 Korea Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
6.1.6 India Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
6.1.8 Australia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Opioid-Induced Constipation Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Opioid-Induced Constipation Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Opioid-Induced Constipation Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Opioid-Induced Constipation Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Opioid-Induced Constipation Sales and Market Share by Application (2015-2020)
7 North America Opioid-Induced Constipation Market Size Categorized by Countries
7.1 North America Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
7.1.1 North America Opioid-Induced Constipation Sales by Countries (2015-2020)
7.1.2 North America Opioid-Induced Constipation Revenue by Countries (2015-2020)
7.1.3 United States Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
7.1.4 Canada Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
7.1.5 Mexico Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
7.2 North America Opioid-Induced Constipation Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Opioid-Induced Constipation Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Opioid-Induced Constipation Sales Market Share by Type (2015-2020)
7.3.2 North America Opioid-Induced Constipation Revenue and Revenue Share by Type (2015-2020)
7.4 North America Opioid-Induced Constipation Sales Market Share by Application (2015-2020)
8 South America Opioid-Induced Constipation Market Size Categorized by Countries
8.1 South America Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
8.1.1 South America Opioid-Induced Constipation Sales by Countries (2015-2020)
8.1.2 South America Opioid-Induced Constipation Revenue by Countries (2015-2020)
8.1.3 Brazil Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
8.2 South America Opioid-Induced Constipation Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Opioid-Induced Constipation Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Opioid-Induced Constipation Sales Market Share by Type (2015-2020)
8.3.2 South America Opioid-Induced Constipation Revenue and Revenue Share by Type (2015-2020)
8.4 South America Opioid-Induced Constipation Sales Market Share by Application (2015-2020)
9 Middle East and Africa Opioid-Induced Constipation Market Size Categorized by Countries
9.1 Middle East and Africa Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Opioid-Induced Constipation Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Opioid-Induced Constipation Revenue by Countries (2015-2020)
9.1.3 GCC Countries Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
9.1.4 Turkey Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
9.1.5 Egypt Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
9.1.6 South Africa Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Opioid-Induced Constipation Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Opioid-Induced Constipation Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Opioid-Induced Constipation Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Opioid-Induced Constipation Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Opioid-Induced Constipation Sales Market Share by Application (2015-2020)
10 Global Opioid-Induced Constipation Market Segment by Type
10.1 Global Opioid-Induced Constipation Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Opioid-Induced Constipation Sales and Market Share by Type (2015-2020)
10.1.2 Global Opioid-Induced Constipation Revenue and Market Share by Type (2015-2020)
10.2 Methylnaltrexone Bromide Sales Growth Rate and Price
10.2.1 Global Methylnaltrexone Bromide Sales Growth Rate (2015-2020)
10.2.2 Global Methylnaltrexone Bromide Price (2015-2020)
10.3 Lubiprostone Sales Growth Rate and Price
10.3.1 Global Lubiprostone Sales Growth Rate (2015-2020)
10.3.2 Global Lubiprostone Price (2015-2020)
10.4 Naloxegol Sales Growth Rate and Price
10.4.1 Global Naloxegol Sales Growth Rate (2015-2020)
10.4.2 Global Naloxegol Price (2015-2020)
10.5 Others Sales Growth Rate and Price
10.5.1 Global Others Sales Growth Rate (2015-2020)
10.5.2 Global Others Price (2015-2020)
11.1 Global Opioid-Induced ConstipationSales Market Share by Application (2015-2020)
11.2 Hospital Sales Growth Rate (2015-2020)
11.3 Pharmacy Sales Growth Rate (2015-2020)
12.1 Global Opioid-Induced Constipation Revenue, Sales and Growth Rate (2020-2025)
12.2 Opioid-Induced Constipation Market Forecast by Regions (2020-2025)
12.2.1 Europe Opioid-Induced Constipation Market Forecast (2020-2025)
12.2.2 APAC Opioid-Induced Constipation Market Forecast (2020-2025)
12.2.3 North America Opioid-Induced Constipation Market Forecast (2020-2025)
12.2.4 South America Opioid-Induced Constipation Market Forecast (2020-2025)
12.2.5 Middle East & Africa Opioid-Induced Constipation Market Forecast (2020-2025)
12.3 Opioid-Induced Constipation Market Forecast by Type (2020-2025)
12.3.1 Global Opioid-Induced Constipation Sales Forecast by Type (2020-2025)
12.3.2 Global Opioid-Induced Constipation Market Share Forecast by Type (2020-2025)
12.4 Opioid-Induced Constipation Market Forecast by Application (2020-2025)
12.4.1 Global Opioid-Induced Constipation Sales Forecast by Application (2020-2025)
12.4.2 Global Opioid-Induced Constipation Market Share Forecast by Application (2020-2025)
13 Analysis of Opioid-Induced Constipation Industry Key Manufacturers
13.1 Takeda Pharmaceuticals
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Takeda Pharmaceuticals Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Takeda Pharmaceuticals News
13.2 Bayer
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Bayer Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Bayer News
13.3 Sanofi
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Sanofi Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Sanofi News
13.4 Mallinckrodt
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Mallinckrodt Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Mallinckrodt News
13.5 Salix (Bausch Health)
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Salix (Bausch Health) Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Salix (Bausch Health) News
13.6 AstraZeneca
13.6.1 Company Details
13.6.2 Product Information
13.6.3 AstraZeneca Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 AstraZeneca News
13.7 Progenics Pharmaceuticals
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Progenics Pharmaceuticals Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Progenics Pharmaceuticals News
13.8 Purdue Pharm
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Purdue Pharm Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Purdue Pharm News
13.9 Nektar Therapeutics
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Nektar Therapeutics Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Nektar Therapeutics News
13.10 Daiichi Sankyo
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Daiichi Sankyo Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Daiichi Sankyo News
13.11 Prestige
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Prestige Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.11.4 Main Business Overview
13.11.5 Prestige News
13.12 GSK
13.12.1 Company Details
13.12.2 Product Information
13.12.3 GSK Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.12.4 Main Business Overview
13.12.5 GSK News
13.13 Shionogi
13.13.1 Company Details
13.13.2 Product Information
13.13.3 Shionogi Opioid-Induced Constipation Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.13.4 Main Business Overview
13.13.5 Shionogi News
15 Appendix
List of Tables and Figures
Figure Opioid-Induced Constipation Picture
Figure Research Programs/Design for This Report
Figure Global Opioid-Induced Constipation Market by Regions (2019)
Table Global Market Opioid-Induced Constipation Comparison by Regions (M USD) 2019-2025
Table Global Opioid-Induced Constipation Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Opioid-Induced Constipation by Type in 2019
Figure Methylnaltrexone Bromide Picture
Figure Lubiprostone Picture
Figure Naloxegol Picture
Figure Others Picture
Figure Hospital Picture
Figure Pharmacy Picture
Table Global Opioid-Induced Constipation Revenue by Manufacturer (2018-2020)
Figure Global Opioid-Induced Constipation Revenue Market Share by Manufacturer in 2019
Table Global Opioid-Induced Constipation Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Opioid-Induced Constipation Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Opioid-Induced Constipation Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Opioid-Induced Constipation Market
Table Key Manufacturers Opioid-Induced Constipation Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioid-Induced Constipation
Table Key Players of Upstream Markets
Table Sales Channel
Figure Sales Channel
Figure Direct Channel Pros & Cons
Table Opioid-Induced Constipation Distributors List
Table Opioid-Induced Constipation Customers List
Figure Global Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Global Opioid-Induced Constipation Revenue and Growth Rate (2015-2020)
Table Global Opioid-Induced Constipation Sales by Regions (2015-2020)
Figure Global Opioid-Induced Constipation Sales Market Share by Regions in 2019
Table Global Opioid-Induced Constipation Revenue by Regions (2015-2020)
Figure Global Opioid-Induced Constipation Revenue Market Share by Regions in 2019
Figure Europe Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure APAC Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure North America Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure South America Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Middle East & Africa Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Europe Opioid-Induced Constipation Revenue and Growth Rate (2015-2020)
Table Europe Opioid-Induced Constipation Sales by Countries (2015-2020)
Table Europe Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)
Figure Europe Opioid-Induced Constipation Sales Market Share by Countries in 2019
Table Europe Opioid-Induced Constipation Revenue by Countries (2015-2020)
Table Europe Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)
Table Europe Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)
Figure Europe Opioid-Induced Constipation Revenue Market Share by Countries in 2019
Figure Germany Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure UK Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure France Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Russia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Italy Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Spain Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Table Europe Opioid-Induced Constipation Revenue by Manufacturer (2018-2020)
Figure Europe Opioid-Induced Constipation Revenue Market Share by Manufacturer in 2019
Table Europe Opioid-Induced Constipation Sales by Type (2015-2020)
Table Europe Opioid-Induced Constipation Sales Share by Type (2015-2020)
Table Europe Opioid-Induced Constipation Revenue by Type (2015-2020)
Table Europe Opioid-Induced Constipation Revenue Share by Type (2015-2020)
Table Europe Opioid-Induced Constipation Sales by Application (2015-2020)
Table Europe Opioid-Induced Constipation Sales Share by Application (2015-2020)
Figure Asia-Pacific Opioid-Induced Constipation Revenue and Growth Rate (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Sales by Countries (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)
Figure Asia-Pacific Opioid-Induced Constipation Sales Market Share by Countries in 2019
Table Asia-Pacific Opioid-Induced Constipation Revenue by Countries (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific Opioid-Induced Constipation Revenue Market Share by Countries in 2019
Figure China Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Japan Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Korea Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure India Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Australia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Revenue by Manufacturer (2018-2020)
Figure Asia-Pacific Opioid-Induced Constipation Revenue Market Share by Manufacturer in 2019
Table Asia-Pacific Opioid-Induced Constipation Sales by Type (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Sales Share by Type (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Revenue by Type (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Revenue Share by Type (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Sales by Application (2015-2020)
Table Asia-Pacific Opioid-Induced Constipation Sales Share by Application (2015-2020)
Figure North America Opioid-Induced Constipation Revenue and Growth Rate (2015-2020)
Table North America Opioid-Induced Constipation Sales by Countries (2015-2020)
Table North America Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)
Figure North America Opioid-Induced Constipation Sales Market Share by Countries in 2019
Table North America Opioid-Induced Constipation Revenue by Countries (2015-2020)
Table North America Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)
Figure North America Opioid-Induced Constipation Revenue Market Share by Countries in 2019
Figure United States Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Canada Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Mexico Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Table North America Opioid-Induced Constipation Revenue by Manufacturer (2018-2020)
Figure North America Opioid-Induced Constipation Revenue Market Share by Manufacturer in 2019
Table North America Opioid-Induced Constipation Sales by Type (2015-2020)
Table North America Opioid-Induced Constipation Sales Share by Type (2015-2020)
Table North America Opioid-Induced Constipation Revenue by Type (2015-2020)
Table North America Opioid-Induced Constipation Revenue Share by Type (2015-2020)
Table North America Opioid-Induced Constipation Sales by Application (2015-2020)
Table North America Opioid-Induced Constipation Sales Share by Application (2015-2020)
Figure South America Opioid-Induced Constipation Revenue and Growth Rate (2015-2020)
Table South America Opioid-Induced Constipation Sales by Countries (2015-2020)
Table South America Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)
Figure South America Opioid-Induced Constipation Sales Market Share by Countries in 2019
Table South America Opioid-Induced Constipation Revenue by Countries (2015-2020)
Table South America Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)
Figure South America Opioid-Induced Constipation Revenue Market Share by Countries in 2019
Figure Brazil Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Table South America Opioid-Induced Constipation Revenue by Manufacturer (2018-2020)
Figure South America Opioid-Induced Constipation Revenue Market Share by Manufacturer in 2019
Table South America Opioid-Induced Constipation Sales by Type (2015-2020)
Table South America Opioid-Induced Constipation Sales Share by Type (2015-2020)
Table South America Opioid-Induced Constipation Revenue by Type (2015-2020)
Table South America Opioid-Induced Constipation Revenue Share by Type (2015-2020)
Table South America Opioid-Induced Constipation Sales by Application (2015-2020)
Table South America Opioid-Induced Constipation Sales Share by Application (2015-2020)
Figure Middle East and Africa Opioid-Induced Constipation Revenue and Growth Rate (2015-2020)
Table Middle East and Africa Opioid-Induced Constipation Sales by Countries (2015-2020)
Table Middle East and Africa Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)
Figure Middle East and Africa Opioid-Induced Constipation Sales Market Share by Countries in 2019
Table Middle East and Africa Opioid-Induced Constipation Revenue by Countries (2015-2020)
Table Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Countries in 2019
Figure GCC Countries Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Egypt Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure Turkey Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Figure South Africa Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
Table Middle East and Africa Opioid-Induced Constipation Revenue by Manufacturer (2018-2020)
Figure Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Manufacturer in 2019
Table Middle East and Africa Opioid-Induced Constipation Sales by Type (2015-2020)
Table Middle East and Africa Opioid-Induced Constipation Sales Share by Type (2015-2020)
Table Middle East and Africa Opioid-Induced Constipation Revenue by Type (2015-2020)
Table Middle East and Africa Opioid-Induced Constipation Revenue Share by Type (2015-2020)
Table Middle East and Africa Opioid-Induced Constipation Sales by Application (2015-2020)
Table Middle East and Africa Opioid-Induced Constipation Sales Share by Application (2015-2020)
Table Global Opioid-Induced Constipation Sales by Type (2015-2020)
Table Global Opioid-Induced Constipation Sales Market Share by Type (2015-2020)
Figure Global Opioid-Induced Constipation Sales Market Share by Type in 2019
Table Global Opioid-Induced Constipation Revenue by Type (2015-2020)
Table Global Opioid-Induced Constipation Revenue Market Share by Type (2015-2020)
Figure Global Opioid-Induced Constipation Revenue Market Share by Type in 2019
Figure Global Methylnaltrexone Bromide Sales Growth Rate (2015-2020)
Figure Global Methylnaltrexone Bromide Price (2015-2020)
Figure Global Lubiprostone Sales Growth Rate (2015-2020)
Figure Global Lubiprostone Price (2015-2020)
Figure Global Naloxegol Sales Growth Rate (2015-2020)
Figure Global Naloxegol Price (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Figure Global Opioid-Induced Constipation Sales Market Share by Application in 2019
Figure Global Hospital Sales Growth Rate (2015-2020)
Figure Global Pharmacy Sales Growth Rate (2015-2020)
Table Global Opioid-Induced Constipation Sales Forecast by Regions (2020-2025)
Table Global Opioid-Induced Constipation Market Share Forecast by Regions (2020-2025
Figure Europe Sales Opioid-Induced Constipation Market Forecast (2020-2025)
Figure APAC Sales Opioid-Induced Constipation Market Forecast (2020-2025)
Figure North America Sales Opioid-Induced Constipation Market Forecast (2020-2025)
Figure South America Sales Opioid-Induced Constipation Market Forecast (2020-2025)
Figure Middle East & Africa Sales Opioid-Induced Constipation Market Forecast (2020-2025)
Table Global Opioid-Induced Constipation Sales Forecast by Type (2020-2025)
Table Global Opioid-Induced Constipation Market Share Forecast by Type (2020-2025)
Table Global Opioid-Induced Constipation Sales Forecast by Application (2020-2025)
Table Global Opioid-Induced Constipation Market Share Forecast by Application (2020-2025)
Table Takeda Pharmaceuticals Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Takeda Pharmaceuticals
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Takeda Pharmaceuticals Opioid-Induced Constipation Market Share (2018-2020)
Table Takeda Pharmaceuticals Main Business
Table Takeda Pharmaceuticals Recent Development
Table Bayer Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Bayer
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bayer Opioid-Induced Constipation Market Share (2018-2020)
Table Bayer Main Business
Table Bayer Recent Development
Table Sanofi Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Sanofi
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sanofi Opioid-Induced Constipation Market Share (2018-2020)
Table Sanofi Main Business
Table Sanofi Recent Development
Table Mallinckrodt Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Mallinckrodt
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Mallinckrodt Opioid-Induced Constipation Market Share (2018-2020)
Table Mallinckrodt Main Business
Table Mallinckrodt Recent Development
Table Salix (Bausch Health) Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Salix (Bausch Health)
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Salix (Bausch Health) Opioid-Induced Constipation Market Share (2018-2020)
Table Salix (Bausch Health) Main Business
Table Salix (Bausch Health) Recent Development
Table AstraZeneca Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of AstraZeneca
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure AstraZeneca Opioid-Induced Constipation Market Share (2018-2020)
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Progenics Pharmaceuticals Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Progenics Pharmaceuticals
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Progenics Pharmaceuticals Opioid-Induced Constipation Market Share (2018-2020)
Table Progenics Pharmaceuticals Main Business
Table Progenics Pharmaceuticals Recent Development
Table Purdue Pharm Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Purdue Pharm
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Purdue Pharm Opioid-Induced Constipation Market Share (2018-2020)
Table Purdue Pharm Main Business
Table Purdue Pharm Recent Development
Table Nektar Therapeutics Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Nektar Therapeutics
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Nektar Therapeutics Opioid-Induced Constipation Market Share (2018-2020)
Table Nektar Therapeutics Main Business
Table Nektar Therapeutics Recent Development
Table Daiichi Sankyo Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Daiichi Sankyo
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Daiichi Sankyo Opioid-Induced Constipation Market Share (2018-2020)
Table Daiichi Sankyo Main Business
Table Daiichi Sankyo Recent Development
Table Prestige Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Prestige
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Prestige Opioid-Induced Constipation Market Share (2018-2020)
Table Prestige Main Business
Table Prestige Recent Development
Table GSK Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of GSK
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure GSK Opioid-Induced Constipation Market Share (2018-2020)
Table GSK Main Business
Table GSK Recent Development
Table Shionogi Company Profile
Figure Opioid-Induced Constipation Product Picture and Specifications of Shionogi
Table Opioid-Induced Constipation Production, Price, Revenue and Gross Margin of 2018-2020
Figure Shionogi Opioid-Induced Constipation Market Share (2018-2020)
Table Shionogi Main Business
Table Shionogi Recent Development
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"